{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:47:36Z","timestamp":1782816456364,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00520-026-10741-8","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:30:53Z","timestamp":1780011053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-9340","authenticated-orcid":false,"given":"Susan","family":"Dent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4372-3204","authenticated-orcid":false,"given":"Michelle B.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-4810","authenticated-orcid":false,"given":"Anne","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-6088","authenticated-orcid":false,"given":"Ahamed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Naa Gogwe","family":"Ayettey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0681-5708","authenticated-orcid":false,"given":"Jose","family":"Alvarez-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-4219","authenticated-orcid":false,"given":"Alexandre","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-2513","authenticated-orcid":false,"given":"Eng-Siew","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul Cordoba","family":"Mascunano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2013-4017","authenticated-orcid":false,"given":"Mridula","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naa Adorkor","family":"Aryeetey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-4395","authenticated-orcid":false,"given":"Erin J.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sase","family":"Kazuhiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2198-5190","authenticated-orcid":false,"given":"Nida","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-9322","authenticated-orcid":false,"given":"Aya F.","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-7637","authenticated-orcid":false,"given":"Cherith J.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2582-9548","authenticated-orcid":false,"given":"Sivatharshini","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9773-5235","authenticated-orcid":false,"given":"Neil M.","family":"Iyenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-4814","authenticated-orcid":false,"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-1642","authenticated-orcid":false,"given":"Bogda","family":"Koczwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"11","key":"10741_CR1","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jnci\/djae135","volume":"116","author":"E Tonorezos","year":"2024","unstructured":"Tonorezos E, et al. Prevalence of cancer survivors in the United States. JNCI: J Natl Cancer Inst. 2024;116(11):1784\u201390.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"3","key":"10741_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","volume":"25","author":"R De Angelis","year":"2024","unstructured":"De Angelis R, et al. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024;25(3):293\u2013307.","journal-title":"Lancet Oncol"},{"issue":"8","key":"10741_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","volume":"35","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893\u2013911.","journal-title":"J Clin Oncol"},{"key":"10741_CR4","doi-asserted-by":"crossref","unstructured":"Ganatra S et al (2026) Diagnosis and management of cardiovascular adverse effects of targeted oncology therapies: Bruton\u2019s Tyrosine Kinase, immune checkpoint, and vascular endothelial growth factor inhibitors: 2025 ACC Concise clinical guidance: a report of the american college of cardiology solution set oversight committee. JACC 87(5):654\u2013682","DOI":"10.1016\/j.jacc.2025.10.018"},{"issue":"8","key":"10741_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1634\/theoncologist.2018-0130","volume":"23","author":"S Ganatra","year":"2018","unstructured":"Ganatra S, Neilan TG. Immune Checkpoint Inhibitor-Associated Myocarditis. Oncologist. 2018;23(8):879\u201386.","journal-title":"Oncologist"},{"issue":"41","key":"10741_CR6","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"3","key":"10741_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s11764-023-01331-2","volume":"18","author":"R Knowles","year":"2024","unstructured":"Knowles R, et al. Reducing the impact of cardiovascular disease in older people with cancer: a qualitative study of healthcare providers. J Cancer Surviv. 2024;18(3):818\u201327.","journal-title":"J Cancer Surviv"},{"issue":"10","key":"10741_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.116.024811","volume":"135","author":"MM Fidler","year":"2017","unstructured":"Fidler MM, et al. Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain. Circulation. 2017;135(10):951\u201363.","journal-title":"Circulation"},{"issue":"7","key":"10741_CR9","first-page":"831","volume":"32","author":"SA Virani","year":"2016","unstructured":"Virani SA, et al. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy. Can J Cardiol. 2016;32(7):831\u201341.","journal-title":"Can J Cardiol"},{"issue":"2","key":"10741_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","volume":"31","author":"G Curigliano","year":"2020","unstructured":"Curigliano G, et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol. 2020;31(2):171\u201390.","journal-title":"Ann Oncol"},{"issue":"11","key":"10741_CR11","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"AR Lyon","year":"2020","unstructured":"Lyon AR, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10741_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","volume":"15","author":"JC Plana","year":"2014","unstructured":"Plana JC, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063\u201393.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10741_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.clon.2022.05.001","volume":"34","author":"LD Cocco","year":"2022","unstructured":"Cocco LD, et al. Global Longitudinal Strain for the Early Detection of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis. Clin Oncol (R Coll Radiol). 2022;34(8):514\u201325.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"25 Pt A","key":"10741_CR14","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10741_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1080\/10428194.2016.1257795","volume":"58","author":"TD Shanafelt","year":"2017","unstructured":"Shanafelt TD, et al. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Leuk Lymphoma. 2017;58(7):1630\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10741_CR16","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","volume":"144","author":"MG Fradley","year":"2021","unstructured":"Fradley MG et al (2021) Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association. Circulation 144(3):e41-55","journal-title":"Circulation"},{"issue":"10374","key":"10741_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(22)02405-9","volume":"401","author":"E Tawfiq","year":"2023","unstructured":"Tawfiq E, et al. Performance of cardiovascular disease risk prediction equations in more than 14\u2008000 survivors of cancer in New Zealand primary care: a validation study. Lancet. 2023;401(10374):357\u201365.","journal-title":"Lancet"},{"issue":"3","key":"10741_CR18","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/HYP.0000000000000224","volume":"80","author":"JB Cohen","year":"2023","unstructured":"Cohen JB et al (2023) Cancer therapy-related hypertension: A scientific statement from the American Heart Association. Hypertension 80(3):e46-57","journal-title":"Hypertension"},{"issue":"2","key":"10741_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaccao.2019.11.012","volume":"1","author":"FA Marvel","year":"2019","unstructured":"Marvel FA, Whelton SP, Blumenthal RS. A Cardio-Oncology Cardiovascular Prevention Framework. JACC CardioOncol. 2019;1(2):252\u20135.","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10741_CR20","first-page":"20","volume":"7","author":"R Altena","year":"2021","unstructured":"Altena R, et al. Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer. Cardiooncology. 2021;7(1):20.","journal-title":"Cardiooncology"},{"issue":"1","key":"10741_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","volume":"393","author":"KS Courneya","year":"2025","unstructured":"Courneya KS, et al. Structured Exercise after Adjuvant Chemotherapy for Colon Cancer. N Engl J Med. 2025;393(1):13\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"10741_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jnci\/djae177","volume":"117","author":"KH Schmitz","year":"2024","unstructured":"Schmitz KH, et al. Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO). JNCI: J Natl Cancer Inst. 2024;117(1):9\u201319.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"10741_CR23","doi-asserted-by":"crossref","unstructured":"Raisi-Estabragh Z et al (2024) Cardiovascular considerations before cancer therapy. Gaps in Evidence and JACC: cardioOncology expert panel recommendations. JACC CardioOncol 6(5):631\u2013654","DOI":"10.1016\/j.jaccao.2024.07.017"},{"key":"10741_CR24","doi-asserted-by":"crossref","unstructured":"Macedo AVS et al (2019) Efficacy of Dexrazoxane in preventing anthracycline cardiotoxicity in breast cancer. JACC CardioOncol 1(1):68\u201379","DOI":"10.1016\/j.jaccao.2019.08.003"},{"key":"10741_CR25","unstructured":"Zinecard\u00ae (dexrazoxane for injection). 2014 [cited January 2026; Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020212s013lbl.pdf"},{"issue":"8","key":"10741_CR26","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/1754-9485.13724","volume":"68","author":"S Birch","year":"2024","unstructured":"Birch S, Otton J. Cardio-oncology and radiation oncology: How collaboration between cardiologists and oncologists can be realised in radiation oncology. J Med Imaging Radiat Oncol. 2024;68(8):962\u201373.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"3","key":"10741_CR27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaccao.2021.06.003","volume":"3","author":"JD Mitchell","year":"2021","unstructured":"Mitchell JD, et al. Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society. JACC CardioOncol. 2021;3(3):360\u201380.","journal-title":"JACC CardioOncol"},{"issue":"2","key":"10741_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","volume":"16","author":"K Banfill","year":"2021","unstructured":"Banfill K, et al. Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions. J Thorac Oncol. 2021;16(2):216\u201327.","journal-title":"J Thorac Oncol"},{"key":"10741_CR29","doi-asserted-by":"crossref","unstructured":"Aznar MC et al (2023) ESTRO-ACROP guideline: recommendations on implementation of breath-hold techniques in radiotherapy. Radiother Oncol 185:109734","DOI":"10.1016\/j.radonc.2023.109734"},{"key":"10741_CR30","doi-asserted-by":"crossref","unstructured":"Dent SF et al (2020) Optimizing cardiovascular health in patients with cancer: a practical review of risk assessment, monitoring, and prevention of cancer treatment\u2013related cardiovascular toxicity. Am Soc Clin Oncol Educ Book 40:501\u2013515","DOI":"10.1200\/EDBK_286019"},{"key":"10741_CR31","doi-asserted-by":"crossref","unstructured":"Bhalraam U et al (2026) Impact of sodium-glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis. Eur J Prev Cardiol 33(2):214\u2013226","DOI":"10.1093\/eurjpc\/zwaf026"},{"issue":"9","key":"10741_CR32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ejhf.1957","volume":"22","author":"J \u010celutkien\u0117","year":"2020","unstructured":"\u010celutkien\u0117 J, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(9):1504\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10741_CR33","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/ejhf.2017","volume":"22","author":"R Pudil","year":"2020","unstructured":"Pudil R, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail. 2020;22(11):1966\u201383.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10741_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","volume":"102","author":"DM Gujral","year":"2016","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016;102(4):269\u201376.","journal-title":"Heart"},{"issue":"6","key":"10741_CR35","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","volume":"118","author":"CG Lenneman","year":"2016","unstructured":"Lenneman CG, Sawyer DB. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment. Circ Res. 2016;118(6):1008\u201320.","journal-title":"Circ Res"},{"issue":"30","key":"10741_CR36","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","volume":"28","author":"HS Haugnes","year":"2010","unstructured":"Haugnes HS, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28(30):4649\u201357.","journal-title":"J Clin Oncol"},{"issue":"4","key":"10741_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.124.070709","volume":"151","author":"HT Dillon","year":"2025","unstructured":"Dillon HT, et al. Preventing Allogeneic Stem Cell Transplant\u2013Related Cardiovascular Dysfunction: ALLO-Active Trial. Circulation. 2025;151(4):292\u2013308.","journal-title":"Circulation"},{"issue":"7","key":"10741_CR38","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","volume":"147","author":"SJ Foulkes","year":"2023","unstructured":"Foulkes SJ, et al. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study. Circulation. 2023;147(7):532\u201345.","journal-title":"Circulation"},{"issue":"29","key":"10741_CR39","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/eurheartj\/ehaf100","volume":"46","author":"SC Adams","year":"2025","unstructured":"Adams SC, et al. Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the ICOS-CORE working group. Eur Heart J. 2025;46(29):2847\u201365.","journal-title":"Eur Heart J"},{"issue":"29","key":"10741_CR40","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong GT, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673\u201380.","journal-title":"J Clin Oncol"},{"issue":"23","key":"10741_CR41","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","volume":"120","author":"SH Armenian","year":"2012","unstructured":"Armenian SH, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120(23):4505\u201312.","journal-title":"Blood"},{"issue":"21","key":"10741_CR42","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","volume":"139","author":"SC Gilchrist","year":"2019","unstructured":"Gilchrist SC et al (2019) Cardio-Oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association. Circulation 139(21):e997-1012","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1007\/s00520-026-10950-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10741-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:30:01Z","timestamp":1782815401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10741-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10741"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10741-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00520-026-10950-1","URL":"https:\/\/doi.org\/10.1007\/s00520-026-10950-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no relevant financial or non-financial interests to dislose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflicts of Interest"}}],"article-number":"590"}}